Cargando…
COVID-19 and Myositis: What We Know So Far
PURPOSE: Myositis as a rare manifestation of COVID-19 is only recently being reported. This review examines the current literature on COVID-19-induced myositis focusing on etiopathogenesis, clinical presentations, diagnostic practices, and therapeutic challenges with immunosuppression, and the diffi...
Autores principales: | Saud, Ahmad, Naveen, R, Aggarwal, Rohit, Gupta, Latika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254439/ https://www.ncbi.nlm.nih.gov/pubmed/34216297 http://dx.doi.org/10.1007/s11926-021-01023-9 |
Ejemplares similares
-
Bone Health in Idiopathic Inflammatory Myopathies: Diagnosis and Management
por: Vincze, Anett, et al.
Publicado: (2021) -
Pneumocystis jirovecii Pneumonia and Other Infections in Idiopathic Inflammatory Myositis
por: Mecoli, Christopher A., et al.
Publicado: (2020) -
Juvenile Dermatomyositis—Clinical Phenotypes
por: Li, Danyang, et al.
Publicado: (2019) -
New Myositis Classification Criteria—What We Have Learned Since Bohan and Peter
por: Leclair, Valérie, et al.
Publicado: (2018) -
Ultrasonography in inflammatory bowel disease – So far we are?
por: Christian, Maaser, et al.
Publicado: (2022)